| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients.
|
Clin Cancer Res
|
2010
|
3.02
|
|
2
|
Diabetes mellitus and breast cancer.
|
Lancet Oncol
|
2005
|
2.34
|
|
3
|
Familial clustering of site-specific cancer risks associated with BRCA1 and BRCA2 mutations in the Ashkenazi Jewish population.
|
Proc Natl Acad Sci U S A
|
2006
|
1.99
|
|
4
|
Pain palliation in patients with bone metastases using MR-guided focused ultrasound surgery: a multicenter study.
|
Ann Surg Oncol
|
2008
|
1.85
|
|
5
|
Attitudes of medical oncologists toward palliative care for patients with advanced and incurable cancer: report on a survery by the European Society of Medical Oncology Taskforce on Palliative and Supportive Care.
|
Cancer
|
2003
|
1.61
|
|
6
|
Adjuvant chemotherapy and whole abdominal irradiation for gastric carcinoma.
|
Tumori
|
2008
|
1.39
|
|
7
|
A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands.
|
Oral Oncol
|
2006
|
1.26
|
|
8
|
Minimally cultured or selected autologous tumor-infiltrating lymphocytes after a lympho-depleting chemotherapy regimen in metastatic melanoma patients.
|
J Immunother
|
2009
|
1.25
|
|
9
|
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.
|
Cancer
|
2006
|
1.13
|
|
10
|
Neoadjuvant imatinib for unresectable gastrointestinal stromal tumor.
|
Anticancer Drugs
|
2004
|
1.10
|
|
11
|
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation.
|
Eur J Cancer
|
2006
|
1.04
|
|
12
|
Parametric diffusion tensor imaging of the breast.
|
Invest Radiol
|
2012
|
0.94
|
|
13
|
Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors.
|
Am J Clin Oncol
|
2007
|
0.87
|
|
14
|
Concurrent chemobiotherapy with cisplatin, dacarbazine, decrescendo interleukin-2 and interferon alpha2b in patients with metastatic melanoma.
|
Oncol Rep
|
2008
|
0.84
|
|
15
|
A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer.
|
Anticancer Res
|
2007
|
0.83
|
|
16
|
A single Mediterranean, possibly Jewish, origin for the Val59Gly CDKN2A mutation in four melanoma-prone families.
|
Eur J Hum Genet
|
2003
|
0.82
|
|
17
|
Radiation rescue for biochemical failure after surgery for prostate cancer: predictive parameters and an assessment of contemporary predictive models.
|
Am J Clin Oncol
|
2006
|
0.81
|
|
18
|
Hormone receptor expression is associated with a unique pattern of metastatic spread and increased survival among HER2-overexpressing breast cancer patients.
|
Am J Clin Oncol
|
2009
|
0.81
|
|
19
|
The management of cancer pain in the elderly.
|
Crit Rev Oncol Hematol
|
2009
|
0.81
|
|
20
|
Association between very young age and adverse characteristics of breast cancer at presentation amongst Israeli women.
|
Am J Clin Oncol
|
2011
|
0.80
|
|
21
|
Adoptive cell therapy for metastatic melanoma patients: pre-clinical development at the Sheba Medical Center.
|
Isr Med Assoc J
|
2006
|
0.79
|
|
22
|
High incidence of fistula formation during bevacizumab treatment in rectal cancer patients.
|
Acta Oncol
|
2007
|
0.78
|
|
23
|
[Body weight, nutritional factors and physical activity--their influence on prognosis after breast cancer diagnosis].
|
Harefuah
|
2006
|
0.78
|
|
24
|
[Three-dimensional conformal radiation therapy concurrent with full dose Gemcitabine for locally advanced inoperable pancreatic cancer].
|
Harefuah
|
2008
|
0.78
|
|
25
|
Salvage prostatic fossa radiation therapy for biochemical failure after radical prostatectomy: the Sheba experience.
|
Isr Med Assoc J
|
2004
|
0.77
|
|
26
|
Germline analysis of thymidine/guanidine polymorphism at position 309 of the Mdm2 promoter in malignant melanoma patients.
|
Melanoma Res
|
2009
|
0.76
|
|
27
|
[Imatinib mesylate (glivec) as a treatment for gastrointestinal stromal tumor (GIST)--long term follow-up].
|
Harefuah
|
2007
|
0.75
|
|
28
|
Serum tumor markers in oncology.
|
Isr Med Assoc J
|
2009
|
0.75
|
|
29
|
Dexrazoxane added to doxorubicin-based adjuvant chemotherapy of breast cancer: a retrospective cohort study with a comparative analysis of toxicity and survival.
|
Anticancer Drugs
|
2017
|
0.75
|
|
30
|
CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.
|
Am J Clin Oncol
|
2002
|
0.75
|
|
31
|
Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer.
|
J Infect Dis
|
2010
|
0.75
|
|
32
|
[Update on the treatment of common gastrointestinal malignancies].
|
Harefuah
|
2005
|
0.75
|
|
33
|
High efficacy of pre-operative trastuzumab combined with paclitaxel following doxorubicin & cyclophosphamide in operable breast cancer.
|
Acta Oncol
|
2008
|
0.75
|
|
34
|
A phase I study of oral UFT given concomitantly with standard preoperative radiotherapy for rectal cancer.
|
Isr Med Assoc J
|
2004
|
0.75
|